newsfilter
← Latest News
Business Wire·

Immunome Announces Pricing of Public Offering of Common Stock

Immunome, Inc. ("Immunome") (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the pricing of an underwritten public offering of